1.       Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Zhou XD, Tao LJ, Li J, Wu LD(通讯作者). Arch Orthop Trauma Surg. 2013 Apr 25. [Epub ahead of print]

2.       Tetrandrine Inhibits the Wnt/ β -Catenin Signalling Pathway and Alleviates Osteoarthritis: An In Vitro and In Vivo Study. Zhou X/Wu L(通讯作者).  Evid Based Complement Alternat Med. 2013;2013:809579. doi: 10.1155/2013/809579. Epub 2013 Mar 5. PMID:23533523[PubMed]浙江大学医学院附属第二医院骨科吴立东

3.       The chondroprotective effects of dehydroepiandrosterone probably exerted by its conversion to estradiol. Li W/Wu L(通讯作者). J Steroid Biochem Mol Biol. 2013 Mar;134:15-22.

4.       Stigmasterol blocks cartilage degradation in rabbit model of osteoarthritis. Chen WP/Wu LD(通讯作者). Acta Biochim Pol. 2012;59(4):537-41.

5.       Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. Yang ZG, Chen WP, Wu LD(通讯作者). J Bone Joint Surg Am. 2012 Jul 3;94(13):1153-9.            

6.       Morin inhibits interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes.Chen WP/Wu LD(通讯作者).  Int Immunopharmacol. 2012 Feb;12(2):447-52. Epub 2012 Jan 11.

7.       Morin exerts antiosteoarthritic properties: an in vitro and in vivo study. Chen WP/Wu LD(通讯作者). Exp Biol Med (Maywood). 2012 Apr;237(4):380-6. Epub 2012 Apr 10.

8.       Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis. Hu PF/Wu LD(通讯作者).  Mol Biol Rep. 2011 Aug;38(6):4225-30. Epub 2010 Nov 30.

9.       Protective effects of berberine in an experimental rat osteoarthritis model. Hu PF/Wu LD(通讯作者). Phytother Res. 2011 Jun;25(6):878-85. doi: 10.1002/ptr.3359. Epub 2010 Nov 24.

10.     Effect of dehydroepiandrosterone on aggrecanase expression in articular cartilage in a rabbit model of osteoarthritis.Huang K/Wu LD(通讯作者). Mol Biol Rep. 2011 Jun;38(5):3569-72.

11.    Anti-arthritic effects of chlorogenic acid in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model. Chen WP/Wu LD(通讯作者). Int Immunopharmacol. 2011 Jan;11(1):23-8.

12.    Effects of diallyl sulphide in chondrocyte and cartilage in experimental osteoarthritis in rabbit. Chen WP/Wu LD(通讯作者). Phytother Res. 2011 Mar;25(3):351-6. doi: 10.1002/ptr.3267.

13.    Increased apelin serum levels and expression in human chondrocytes in osteoarthritic patients. Hu PF/Wu LD(通讯作者). Int Orthop. 2011 Sep;35(9):1421-6.

14.    The emerging role of adipokines in osteoarthritis: a narrative review. Hu PF/Wu LD(通讯作者). Mol Biol Rep. 2011 Feb;38(2):873-8. Epub 2010 May 18.

15.   Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis. Chen WP/Wu LD(通讯作者).  Rheumatol Int. 2011 Oct;31(10):1325-31.

16.   Lubricin: a novel potential biotherapeutic approaches for the treatment of osteoarthritis.  Bao JP/Wu LD(通讯作者). Mol Biol Rep. 2011 Jun;38(5):2879-85.

17.    Thymoquinone inhibits matrix metalloproteinase expression in rabbit chondrocytes and cartilage in experimental osteoarthritis.Chen WP/Wu LD(通讯作者).  Exp Biol Med (Maywood). 2010 Dec;235(12):1425-31. IF: 2.635

18.   Apelin plays a catabolic role on articular cartilage: in vivo and in vitro studies. Hu PF/Wu LD(通讯作者).  Int J Mol Med. 2010 Sep;26(3):357-63. IF: 1.98

19.    Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis. Chen WP/Wu LD（通讯作者）. Clin Chem Lab Med. 2010 Aug;48(8):1141-5. IF: 1.886

20.   Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis.  Chen WP/Wu LD（通讯作者）. Mol Biol Rep. 2010 Dec;37(8):3967-72. Epub 2010 Mar 17. IF: 2.038

21.    Leptin plays a catabolic role on articular cartilage. Bao JP/Wu LD（通讯作者）. Mol Biol Rep. 2010 Oct;37(7):3265-72. Epub 2009 Oct 30. IF: 2.038

22.   Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis? Huang K/Wu LD（通讯作者）.  Mol Biol Rep. 2010 Mar;37(3):1241-5. Epub 2009 Mar 10. IF: 2.038

23.    Visfatin: a Potential Therapeutic Target for Rheumatoid Arthritis. Bao JP, Chen WP, Wu LD(通讯作者). J Int Med Res. 2009 Nov-Dec;37(6): 1655-1661

24.    Combined use of extensively porous coated femoral components with onlay cortical strut allografts in revision of Vancouver B2 and B3 periprosthetic femoral fractures. Wu HB, Yan SG, Wu LD, et al. Chin Med J (Engl). 2009 Nov 5;122(21):2612-5.

25.    Variation patterns of two degradation enzyme systems in articular cartilage in different stages of osteoarthritis: regulation by dehydroepiandrosterone. Bao JP/Wu LD(通讯作者). Clin Chim Acta. 2009 Oct;408(1-2):1-7.

26.    Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells. Xiong Y/Wu LD(通讯作者). J Int Med Res. 2009 Mar-Apr;37(2):407-16.

27.    YKL-40: a potential biomarker for osteoarthritis. Huang K, Wu LD(通讯作者). J Int Med Res. 2009 Jan-Feb;37(1):18-24. Review.

28.    Aggrecanase and aggrecan degradation in osteoarthritis: a review.Huang K, Wu LD(通讯作者).  J Int Med Res. 2008 Nov-Dec;36(6):1149-60. Review.

29.   Use of mid-vastus approach in less invasive primary total knee arthroplasty. Dai XS, Yu XZ, Wu LD, et al.  Chin Med J (Engl). 2008 May 5;121(9):787-90.

30.    Position of the prosthesis and the incidence of dislocation following total hip replacement.He RX, Yan SG, Wu LD, et al.  Chin Med J (Engl). 2007 Jul 5;120(13):1140-4.

31.    Effects of rhBMP-2 on cortical strut allograft healing to the femur in revision total hip arthroplasties: an experimental study.Wu LD(通讯作者), Xiong Y, Yu HC.  Int Orthop. 2007 Oct;31(5):605-11. Epub 2006 Nov 23.

32.    Effect of dehydroepiandrosterone on cartilage and synovium of knee joints with osteoarthritis in rabbits.Wu LD(通讯作者), Yu HC, Xiong Y, Feng J.  Rheumatol Int. 2006 Nov;27(1):79-85. Epub 2006 Oct 11.

33.    Femoral component revision using extensively porous-coated cementless stem. Wu LD(通讯作者), Xiong Y, Yan SG, Yang QS, Dai XS. Chin J Traumatol. 2005 Dec;8(6):358-63.

34.    Total knee replacement for posttraumatic degenerative arthritis of the knee. Wu LD(通讯作者), Xiong Y, Yan SG, Yang QS. Chin J Traumatol. 2005 Aug;8(4):195-9.

35.    A long-term follow-up study of high tibial osteotomy for medial compartment osteoarthrosis. Wu LD, Hahne HJ, Hassenpflug J.Chin J Traumatol. 2004 Dec;7(6):348-53.

36.     [Total hip arthroplasty with uncemented cup and femoral head autografts for coxarthrosis due to dysplasia]Wu LD(通讯作者), Xiong Y, Yan SG, Yang QS, He RX, Wang QH. Zhonghua Wai Ke Za Zhi. 2004 Aug 22;42(16):1006-9. Chinese.

37.    Total hip arthroplasty with cementless cups and femoral head autografts for patients with hip dysplasia and osteoarthritis. Wu LD(通讯作者), Jin LB, Yan SG, Yang QS, Dai XS, Wang XH. Chin J Traumatol. 2004 Oct;7(5):280-5.

38.   The dimensional accuracy of preparation of femoral cavity in cementless total hip arthroplasty.  Wu LD(通讯作者), Hahne HJ, Hassenpflug J. J Zhejiang Univ Sci. 2004 Oct;5(10):1270-8.

39.    [A long-term follow-up study of high tibial osteotomy in medial compartment osteoarthrosis] Wu LD(通讯作者), Hahne HJ, Hassenpflug J. Zhonghua Wai Ke Za Zhi. 2004 Apr 22;42(8):474-7. Chinese.

40.    Treatment of ipsilateral hip and femoral shaft fractures with reconstructive intramedullary interlocking nail.Wu LD(通讯作者), Wu QH, Yan SG, Pan ZJ.  Chin J Traumatol. 2004 Feb;7(1):7-12.

41.    Treatment of comminuted trochanteric fractures and non-union of trochanteric osteotomy in revision total hip arthroplasty. Wu LD(通讯作者), Bernasek TL. Chin J Traumatol. 2003 Oct;6(5):265-9.

42.    [Expanded excision of sternal tumor with iliac bone grafting for reconstruction of the sternum] Xu SW, Wu LD, Chai Y, Wang HT, Shen G. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2002 Aug;31(6):472-473. Chinese.